Thursday, 11 January 2018

Food Therapy: Eggplant in Reduced Risk and Treatment of Hyperlipidemia

Kyle J. Norton 

Eggplant may have a potential and substantial effect in reduced risk and treatment of hypercholesterolemia, some scientists suggested.

Eggplant is a species of S. melongena with deeply purple color, belongings to the family Solanaceae and native to India, cultivated in southern and eastern Asia since prehistory.

Hypercholesterolemia is a common genetic disorder of cholesterol metabolism characterized by abnormal high low-density lipoprotein cholesterol (LDL-C) levels, one of the leading cause of cardiovascular disease.

Hyperlipidemia is a chronic condition of abnormal high levels of blood cholesterol.

According to statistic, approximately 78 million U.S. adults (nearly 37%) had abnormal high blood  cholesterol levels in US in 2012.

In the investigation of the blood lipid effect of four eggplant varieties on lipid indices in 108 adult albino rats for 4 weeks (30days), assigned to 2 major groups (fed with 10% and 20% eggplant supplementation) with four sub groups (Groups A-D) and remainder rat assigned to control group fed with commercial feed, at the end of experiment, researchers found that all groups fed with eggplant supplement regardless to doses exhibit a significant lower blood cholesterol in compared to control group.

Further analysis indicated that administration of diet supplemented at dose of 10% and 20% of S. aetheopicum and S. gilo in rat group showed a highest of  9.92 and 9.53 and lowest 7.65 and 5.95g weight gain respectively.

Levels of cholesterol concentration of (60.76±1.7mg/dl) also was found significant lower in the 20% S. gilo supplemented diet rat group in compared to control and levels of HDL concentration significantly increased in rats placed on 10% and 20% S. macrocarpon (oval) and S. gilo supplemented diet respectively relative to the control group.

The results finding indicated that all 4 varieties of eggplant exerted s strong effect in displayed weight reduction and improved hypolipidemic levels. 

Although Solanum gilo and S. macrocarpon (oval) displayed higher hypocholesterolemia than other 2 groups, over all, all groups increased HDL and reduced weight gain in tested subjects. 

Dr. OSSAMULU, the lead author, after taking into account of other con founders said, "(The findings suggested that eggplant) can be employed in the management of overweight and several cardiovasular diseases".

In the study to test the efficacy of dried powdered fruits of eggplant (Solanum melongena) used in traditional medicine in Bazil for treatment of human hyperlipidemia, researchers at the the joint study lead by the Instituto de Endocrinologia de Maringá conducted a double-blind placebo-controlled study to test the effectiveness of oral Solanum melongena (SM) in a total of 41 hyperlipidemic volunteers allocated to active treatment (n= 21, received two capsules containing SM (450 mg) or placebo (n= 20, 450 mg) twice a day for 3 months, indicated that there were no significant difference of levels of serum triglycerides, HDL-c, VLDL-c, AST, ALT, gGT, glucose and body mass index, in the group treated with SM in compared to placebo.

And both groups expressed the same levels of decrease of levels of serum total cholesterol, LDL-c and LDL-c/HDL-c.

The result of the findings prompted Dr. Silvard fruits), require further clinical trials before being recommended to treat hyperlipidemia".

Contrast to the above study, oral application of infusion of a powdered preparation of the eggplant fruit of 38 hypercholesterolemic human volunteers, receiving either S. melongena infusion (N = 19) or placebo (N = 19) participated in two clinical experiments, exhibited a strong effect in significantly reduced the blood levels of total and LDL cholesterol and of apolipoprotein B in compared to control, according to the Intraindividual analysis.

However, after taking into account of dietary orientation, researchers suggested that  no intra- or intergroup differences were seen for any of the parameters analyzed.

Dr. Guimarães PR, the lead scientist at the Instituto de Ciências Biológicas said, " S. melongena infusion had a modest and transitory effect, which was not different from that obtained with standard orientation for dyslipidemia patients (diet and physical activities)".

Taking altogether, although there are no universal confirmation, eggplant may have potential and therapeutic effect in reduced risk and treatment of hyperlipidemia pending to further investigation.

For More information of yoga lessons tailor to a complete well being for women, please visit: YOGA FOR WOMEN

Back to Kyle J. Norton Home page

Author Biography
Kyle J. Norton (Scholar, Master of Nutrients, All right reserved)
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

(1) Eggplant (Solanum melongena) infusion has a modest and transitory effect on hypercholesterolemic subjects, Brazilian Journal of Medical and Biological Research
On-line version ISSN 1414-431X Braz J Med Biol Res vol.33 n.9 Ribeirão Preto Sept. 2000
(2) Hypolipidemic Properties of Four Varieties of Eggplants (Solanum melongena L.) by ,OSSAMULU, I, feanyi Famous; 2,AKANYA, Helmina Olufunmilayo; 3,JIGAM, Ali Audu; 4,EGWIM , Evans Chidi 5,ADEYEMI, Henry Yemi, International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 – 6718, ISSN (Print): 2319 – 670X Volume 3 Issue 8 ‖ August 2014 ‖ PP.47-54
(3) [Absence of hypolipidemic effect of Solanum melongena L. (eggplant) on hyperlipidemic patients].[Article in Portuguese] by Silva GE1, Takahashi MH, Eik Filho W, Albino CC, Tasim GE, Serri Lde A, Assef AH, Cortez DA, Bazotte RB.(PubMed)

No comments:

Post a comment